🇺🇸 FDA
Pipeline program

Leukocyte-Poor Platelet Rich Plasma (LP-PRP)

2019-13

Phase 2 mab active

Quick answer

Leukocyte-Poor Platelet Rich Plasma (LP-PRP) for Osteoarthritis, Knee is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Osteoarthritis, Knee
Phase
Phase 2
Modality
mab
Status
active

Clinical trials